Proteinaceous inclusions in neurons, composed primarily of α-synuclein, define the pathology in several neurodegenerative disorders. Neurons can internalize α-synuclein fibrils that can seed new inclusions from endogenously expressed α-synuclein. The factors contributing to the spread of pathology and subsequent neurodegeneration are not fully understood, and different compositions and concentrations of fibrils have been used in different hosts. Here, we systematically vary the concentration and length of well-characterized α-synuclein fibrils and determine their relative ability to induce inclusions and neurodegeneration in different hosts (primary neurons, C57BL/6 J and C3H/HeJ mice, and Sprague Dawley rats). Using dynamic-light scattering profiles and other measurements to determine fibril length and concentration, we find that femptomolar concentrations of fibrils are sufficient to induce robust inclusions in primary neurons. However, a narrow and non-linear dynamic range characterizes fibril-mediated inclusion induction in axons and the soma. In mice, the C3H/HeJ strain is more sensitive to fibril exposures than C57BL/6 J counterparts, with more inclusions and dopaminergic neurodegeneration. In rats, injection of fibrils into the substantia nigra pars compacta (SNpc) results in similar inclusion spread and dopaminergic neurodegeneration as injection of the fibrils into the dorsal striatum, with prominent inclusion spread to the amygdala and several other brain areas. Inclusion spread, particularly from the SNpc to the striatum, positively correlates with dopaminergic neurodegeneration. These results define biophysical characteristics of α-synuclein fibrils that induce inclusions and neurodegeneration both in vitro and in vivo, and suggest that inclusion spread in the brain may be promoted by a loss of neurons.
Introduction
α-Synuclein (α-syn) is the major component of filamentous inclusions in neurons found throughout the brain in several neurodegenerative diseases including Parkinson disease (PD) and Lewy body dementias (LBD) (Spillantini et al., 1998; Spillantini et al., 1997) . Although there is evidence supporting pathological α-syn spread across interconnected neuronal networks, how this relates to selective vulnerability and neurodegeneration remains unclear (Surmeier et al., 2017) . Recently, it has been demonstrated that the addition of pre-formed α-syn fibrils to neurons in vivo or in culture leads to the uptake of these particles and the corruption of endogenous α-syn into inclusions over time (Luk et al., 2012; Luk et al., 2009; Volpicelli-Daley et al., 2011) .
Injection of α-syn fibrils into the rodent striatum, somatosensory cortex, entorhinal cortex, olfactory bulb, substantia nigra pars compacta (SNpc), or muscle, show that the fibrils induce inclusions that resemble those found in PD and LBD (Luk et al., 2012 ) (Masuda-Suzukake et al., 2014 Masuda-Suzukake et al., 2013; Rey et al., 2016 ) (Ayers et al., 2017 Paumier et al., 2015) . In vivo imaging of cortical neurons previously exposed to fibrils demonstrates the overall cytotoxic nature of the inclusion (Osterberg et al., 2015) . These inclusions are found at the site of injection and in interconnected brain regions. Thus, exposure of neurons to α-syn fibrils recapitulates several features of PD and LBD such as selective neuronal vulnerability, pathology in multiple brain regions, and progressive loss of neurons, without the need for genetic manipulation or over-expression of the protein that fibrillizes (i.e., α-syn).
Although it is clear that fibril exposure eventually leads to the death of some neurons, the relationship of the spread of pathology in the brain and overt cell loss (i.e., neurodegeneration) has not been well described. The degeneration of a neuron with inclusions that otherwise would transmit fibrils to neighboring neurons may prevent inclusion spread. Alternatively, cell loss may promote spread through an uncontrolled release of toxic species and fibrils. Further clouding interpretation of past studies using fibrils, the unknown or unreported concentrations of Neurobiology of Disease 105 (2017) [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] 
